Ispire Technology Inc. Common Stock (ISPR) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, ISPR trades at $2.13 with a market cap of $92.70M and a P/E ratio of -3.48. ISPR moved -4.65% today. Year to date, ISPR is -26.48%; over the trailing twelve months it is -18.22%. Its 52-week range spans $1.19 to $7.47. Analyst consensus is buy with an average price target of $6.50. Rallies surfaces ISPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ispire Forms JV with Jincheng Pharma to Enter $7B Nicotine Pouch Market: Ispire Technology has entered a joint venture with Shandong Jincheng Pharmaceutical Group to manufacture and commercialize nicotine pouches, leveraging Jincheng’s pharmaceutical-grade manufacturing and Ispire’s global distribution. The global nicotine pouch market, valued at $7 billion in 2025, is projected to grow 25% annually to over $40 billion by 2033.
| Metric | Value |
|---|---|
| Price | $2.13 |
| Market Cap | $92.70M |
| P/E Ratio | -3.48 |
| EPS | $-0.60 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.47 |
| 52-Week Low | $1.19 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $89.46M |
| Net Income | $-34.17M |
| Gross Margin | 14.63% |
1 analysts cover ISPR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.50.